Visgeneer Inc. (4197.TWO)

TWD 9.77

(0.0%)

Market Cap (In TWD)

294.86 Million

Revenue (In TWD)

147.99 Million

Net Income (In TWD)

-19.58 Million

Avg. Volume

8449.00

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
8.8-12.55
PE
-
EPS
-
Beta Value
0.229
ISIN
TW0004197009
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Kengshuo Dai
Employee Count
-
Website
https://www.visgeneer.com.tw
Ipo Date
2013-10-24
Details
Visgeneer Inc. provides health solutions in the fields of medical device, cosmetics and skin care, bacterial fermentation, and cancer gene diagnostics in Europe and Asia. The company offers blood glucose and ketone, uric acid, and cholesterol monitoring systems. It also provides functional masks, such as wood pulp mask, invisible mask, black mask, pure cloth mask, and bio cellulose mask; face cream, night cream, day cream, wrinkle cream, repairing cream, whitening cream, exfoliating cream, toner, and lotions; functional essences; body lotion and spa clay mask; physical blocker, chemical blocker, and comprehensive sun protection; face wash, wash cream, cleaning cleansing mousse, cleaning cleansing gel, shampoo, and body wash; hand cream, knee cream, foot mask, hand mask, and glucosamine cream; anti-acne cream, female private cleaning lotion, skin care, skin capsules, and hair capsules; and customized skin care products. In addition, the company offers eBmonitor Blood Monitoring System, CoreSence Skincare, BOWIL Skincare, and ZeaSight EU Patent Zeaxanthin, as well as contract manufacturing services. Visgeneer Inc. was founded in 2005 and is based in Hsinchu City, Taiwan.